| Literature DB >> 28659375 |
Hongling Huang1,2, Saar Vandekeere1,2, Joanna Kalucka1,2, Laura Bierhansl1,2, Annalisa Zecchin1,2, Ulrike Brüning1,2, Asjad Visnagri3, Nadira Yuldasheva3, Jermaine Goveia1,2, Bert Cruys1,2, Katleen Brepoels1,2, Sabine Wyns1,2, Stephen Rayport4,5, Bart Ghesquière1,2, Stefan Vinckier1,2, Luc Schoonjans1,2, Richard Cubbon3, Mieke Dewerchin1,2, Guy Eelen1,2, Peter Carmeliet6,2.
Abstract
Endothelial cell (EC) metabolism is emerging as a regulator of angiogenesis, but the precise role of glutamine metabolism in ECs is unknown. Here, we show that depriving ECs of glutamine or inhibiting glutaminase 1 (GLS1) caused vessel sprouting defects due to impaired proliferation and migration, and reduced pathological ocular angiogenesis. Inhibition of glutamine metabolism in ECs did not cause energy distress, but impaired tricarboxylic acid (TCA) cycle anaplerosis, macromolecule production, and redox homeostasis. Only the combination of TCA cycle replenishment plus asparagine supplementation restored the metabolic aberrations and proliferation defect caused by glutamine deprivation. Mechanistically, glutamine provided nitrogen for asparagine synthesis to sustain cellular homeostasis. While ECs can take up asparagine, silencing asparagine synthetase (ASNS, which converts glutamine-derived nitrogen and aspartate to asparagine) impaired EC sprouting even in the presence of glutamine and asparagine. Asparagine further proved crucial in glutamine-deprived ECs to restore protein synthesis, suppress ER stress, and reactivate mTOR signaling. These findings reveal a novel link between endothelial glutamine and asparagine metabolism in vessel sprouting.Entities:
Keywords: angiogenesis; asparagine; endothelial cell; glutamine; metabolism
Mesh:
Substances:
Year: 2017 PMID: 28659375 PMCID: PMC5556263 DOI: 10.15252/embj.201695518
Source DB: PubMed Journal: EMBO J ISSN: 0261-4189 Impact factor: 11.598